NIKKI JACINTO: Open Payments
NPI 1326651118 · DURANT, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 24 payments from 15 companies in 2025. Trend: 2023 $891 · 2024 $621 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $112 |
| Lilly USA, LLC | 1 | $71 |
| Alkermes, Inc. | 3 | $60 |
| PFIZER INC. | 1 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Ozempic, ZEPBOUND, NURTEC ODT, GEMTESA, ARISTADA, VRAYLAR, CAPLYTA, JOURNAVX.
Industry payments across OK — which companies pay providers there.
